Cooper MH - Search Results

1

Cross-species graft-versus-host-disease is accompanied by a donor-derived cellular immune response.

Cooper MH, Nalesnik MA, Watkins SC, Hoffman RA, Ildstad ST. Cooper MH, et al. Transplantation. 1993 Oct;56(4):934-40. doi: 10.1097/00007890-199310000-00030. Transplantation. 1993. PMID: 8212220

2

Xenogeneic graft-versus-host disease is associated with elevated levels of reactive nitrogen intermediates.

Cooper MH, Hoffman RA, Jacob TD, Nalesnik MA, DiSilvio M, Ildstad ST. Cooper MH, et al. Transplant Proc. 1992 Dec;24(6):2872-3. Transplant Proc. 1992. PMID: 1465978 No abstract available.

3

Cross species graft-versus-host disease induces hepatic injury in association with a donor-derived cellular immune response.

Cooper MH, Nalesnik MA, Watkins SC, Schachter MJ, Ildstad ST. Cooper MH, et al. Transplant Proc. 1993 Feb;25(1 Pt 2):1283. Transplant Proc. 1993. PMID: 8442113 No abstract available.

4

Experience with posttransplant lymphoproliferative disorders in solid organ transplant recipients.

Nalesnik MA, Locker J, Jaffe R, Reyes J, Cooper M, Fung J, Starzl TE. Nalesnik MA, et al. Clin Transplant. 1992;6(Spec):249-252. Clin Transplant. 1992. PMID: 21151749 Free PMC article.

5

Posttransplant lymphoproliferative disorders occurring under primary FK 506 immunosuppression.

Reyes J, Tzakis A, Green M, Nour B, Nalesnik M, Van Thiel D, Martin M, Breinig MK, Fung JJ, Cooper M, et al. Reyes J, et al. Transplant Proc. 1991 Dec;23(6):3044-6. Transplant Proc. 1991. PMID: 1721355 Free PMC article. No abstract available.

6

Prolonged prevention of acute graft-versus-host disease after allogeneic bone marrow transplantation by donor pretreatment using FK 506.

Cooper MH, Markus PM, Cai X, Starzl TE, Fung JJ. Cooper MH, et al. Transplant Proc. 1991 Dec;23(6):3238-9. Transplant Proc. 1991. PMID: 1721421 Free PMC article. No abstract available.

7

The induction of pseudo-graft-versus-host disease following syngeneic bone marrow transplantation using FK 506.

Cooper MH, Hartman GG, Starzl TE, Fung JJ. Cooper MH, et al. Transplant Proc. 1991 Dec;23(6):3234-5. Transplant Proc. 1991. PMID: 1721419 Free PMC article. No abstract available.

8

Short-term myeloid reconstitution following TBI is not adversely affected by doses of FK506 that abrogate lethal GVHD.

Cooper MH, Patrene KD, Vecchini F, Austin CA, Markus PM, Boggs SS. Cooper MH, et al. Bone Marrow Transplant. 1994 Sep;14(3):355-62. Bone Marrow Transplant. 1994. PMID: 7527689

9

Rapamycin but not FK506 inhibits the proliferation of mononuclear phagocytes induced by colony-stimulating factors.

Cooper MH, Gregory SH, Starzl TE, Wing EJ. Cooper MH, et al. Transplantation. 1994 Feb;57(3):433-9. doi: 10.1097/00007890-199402150-00021. Transplantation. 1994. PMID: 7509089 Free PMC article.

10

The effect of cyclosporine, rapamycin and FK 506 the survival following allogeneic bone marrow transplantation.

Markus PM, Cai X, Selvaggi G, Cooper M, Harnaha J, Fung JJ, Starzl TE. Markus PM, et al. Transplant Proc. 1991 Dec;23(6):3232-3. Transplant Proc. 1991. PMID: 1721418 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

95 results

Search Page

Filters